2D Nanomaterials for Medical Applications

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: 20 July 2024 | Viewed by 193

Special Issue Editors


E-Mail Website
Guest Editor
Departamento de Bioingeniería, Universidad Carlos III de Madrid, Avda. de la Universidad, 30, 28911 Leganés, Madrid, Spain
Interests: 2D nanomaterials; graphene; hydrogels; tissue engineering; bioprinting; biomedicine
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Regional Institute of Applied Scientific Research (IRICA), University of Castilla-La Mancha, Av. Camilo José Cela, 13005 Ciudad Real, Spain
Interests: nanomaterials; synthesis; characterization; CVD
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In the dynamic world of nanotechnology, the versatility of 2D nanomaterials has ignited a revolution in the field of medicine. Nanomaterials is pleased to announce a unique opportunity for researchers, scientists, and professionals to contribute to our Special Issue on "2D Nanomaterials for Medical Applications".

This Special Issue aims to explore the cutting-edge applications of two-dimensional nanomaterials in the realm of medicine. We invite authors to share their innovative research, novel findings, and groundbreaking developments, all aimed at pushing the boundaries of medical science using these remarkable materials.

We seek high-quality, original research articles, reviews, and perspective papers that encompass, but are not limited to, the following areas:

  • Biocompatible 2D nanomaterials for drug delivery;
  • 2D nanomaterials for bioimaging and diagnostics;
  • Tissue engineering and regenerative medicine with 2D nanomaterials;
  • 2D nanomaterials in targeted therapy and precision medicine;
  • Toxicology and safety considerations of 2D nanomaterials in medical applications;
  • Scaling up 2D nanomaterial synthesis for practical medical use.

Our distinguished editorial board welcomes contributions from experts in the field, and our rigorous peer-review process ensures the publication of high-impact research. We look forward to receiving your contributions.

Dr. Cristina Martín
Dr. Viviana Jehová González Velázquez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • 2D nanomaterials
  • medical applications
  • drug delivery
  • bioimaging
  • tissue engineering
  • regenerative medicine
  • precision medicine
  • toxicology
  • synthesis
  • biocompatible nanomaterials

Published Papers

This special issue is now open for submission.
Back to TopTop